Louisiana Record

Monday, October 14, 2019

Parents' Zofran lawsuit blames generic drug for birth defects

By Robert Hadley | Mar 4, 2016

NEW ORLEANS – The parents of two children are suing pharmaceutical giant GlaxoSmithKline for fetal damage allegedly caused by the generic form of the drug Zofran.

Trish and Bryce Belanger, individually and on behalf of their minor children, filed a lawsuit March 3 in U.S. District Court for the Eastern District of Louisiana against GlaxoSmithKline LLC, alleging product liability, breach of express warranty and other counts.

According to the complaint, the plaintiffs’ two children were born in 2009 and 2010, respectively, with numerous birth defects allegedly caused by Trish Belanger’s prescribed use of the generic form of Zofran to treat morning sickness. The parents claim GlaxoSmithKline knew Zofran, a drug originally used to battle nausea in chemotherapy patients, was dangerous for expectant mothers, but continued to market the drug with inadequate warning labels.

The Belangers seek a jury trial and compensatory damages including reimbursement for the drug’s costs, medical expenses, interest and attorneys’ fees in an amount to be determined at trial. They are represented by attorneys John D. SIleo and Casey W. Moll in New Orleans.

U.S. District Court for the Eastern District Case number 2:16-cv-01806

Want to get notified whenever we write about any of these organizations ?

Sign-up Next time we write about any of these organizations, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

GlaxoSmithKline U.S. District Court for the Eastern District of Louisiana

More News